MedTrace Logo

Hip Muscle Power, Lateral Balance Function, and Falls in Aging

NCT03731572 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2026-01-26

No results posted yet for this study

Summary

Falls and their consequences are among the major problems in the medical care of older individuals. The long-term goal of this research is to develop a mechanistically based therapeutic intervention to enhance muscle power, weight-shifting capability, and lateral balance function through protective stepping to prevent falls. When human balance is challenged, protective stepping is a vital strategy for preventing a fall during activities of daily life. Many older people at risk for falls have particular difficulties with successfully stepping sideways as a protective response to loss of balance in the lateral direction. Age-related declines in lateral balance function result from neuromuscular and biomechanical limitations in hip abductor-adductor muscle power generation. This study will test whether these impairments can be improved with high-velocity hip muscle resistance power training that will be more effective than conventional resistance strength training.

Conditions

  • Accidental Falls

Interventions

OTHER

Power Training

Hip abductor-adductor resistance exercises at maximum execution speed

OTHER

Strength Training

Hip abductor-adductor resistance exercises at reduced execution speed

Sponsors & Collaborators

  • VA Maryland Health Care System

    collaborator FED

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Vicki L Gray, PhD · University of Maryland, Baltimore

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-16
Primary Completion
2026-01-10
Completion
2026-01-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03731572 on ClinicalTrials.gov